EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Downregulating DNA methyltransferase 3B by suppressing the PI3K/Akt signaling pathway enhances the chemosensitivity of glioblastoma to temozolomide

Wenwu Kan, Linhui Gao, Jingnan Chen, Li Chen, Guojun Zhang, Bilie Hao, Min He, Xudong Chen, Cheng Wang

Molecular Neurobiology · 2024-09 · 61 (9) · 7066-7074

DOI: 10.1007/s12035-024-04041-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Neurobiology, online erschienen am 17.02.2024. Verfasst von Wenwu Kan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, 310011, Zhejiang, China. Hauptthemen laut MEDLINE: Temozolomide, DNA Methyltransferase 3B, DNA (Cytosine-5-)-Methyltransferases, Glioblastoma. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zhejiang Traditional Chinese Medicine Administration.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma (GBM) is the most common malignant brain tumor and has the poorest prognosis attributed to its chemoresistance to temozolomide (TMZ), the first-line drug for treating GBM. TMZ resistance represents a significant obstacle to successful GBM treatment, necessitating the development of new strategies to overcome this resistance and augment the chemosensitivity of GBM cells to TMZ. This study established a TMZ-resistant U251 (U251-TMZ) cell line by exposing it to increasing doses of TMZ in vitro. We focused on the DNA methyltransferase 3B (DNMT3B) gene, phosphorylated Akt (p-Akt), total Akt (t-Akt), phosphorylated PI3K (p-PI3K), and total PI3K (t-PI3K) protein expression. Results showed that the DNMT3B gene was significantly upregulated in the U251-TMZ cell line. The p-Akt and p-PI3K protein expression in U251-TMZ cells was also significantly elevated. Moreover, we found that DNMT3B downregulation was correlated with the increased chemosensitivity of GBM cells to TMZ. LY294002 suppressed the PI3K/Akt signaling pathway, leading to a notable inhibition of PI3K phosphorylation and a significant decrease in DNMT3B expression in U251-TMZ cells. Given that DNMT3B expression is mediated by the PI3K/Akt signaling pathway, its downregulation further increased the chemosensitivity of GBM cells to TMZ and therefore is a promising therapeutic for GBM treatment. Our results suggested that DNMT3B downregulation can inhibit the proliferation of GBM cells and induce GBM cell apoptosis in vitro. In addition, the PI3K/Akt signaling pathway plays an important role in the chemosensitivity of GBM cells to TMZ by regulating DNMT3B expression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TemozolomideDNA Methyltransferase 3BDNA (Cytosine-5-)-MethyltransferasesGlioblastomaSignal TransductionProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesDown-RegulationHumansCell Line, TumorDrug Resistance, NeoplasmDacarbazineBrain NeoplasmsGene Expression Regulation, NeoplasticAntineoplastic Agents, AlkylatingPhosphorylation

Stichwörter der Autor:innen

ChemoresistanceDNMT3BGlioblastomaTemozolomide

Substanzen

TemozolomideDNA Methyltransferase 3BDNA (Cytosine-5-)-MethyltransferasesProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesDacarbazineAntineoplastic Agents, Alkylating

Autor:innen und Institutionen

  • Department of Neurosurgery, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, 310011, Zhejiang, China.
  • The First Clinical Medical College of Zhejiang, Chinese Medical University, Hangzhou, 310053, Zhejiang, China.
  • Department of Neurosurgery, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, 310011, Zhejiang, China. xh_wangcheng@163.com.

Förderung

  • Zhejiang Traditional Chinese Medicine Administration

Zitieren

APA

Kan, W., Gao, L., Chen, J., Chen, L., Zhang, G., Hao, B., He, M., Chen, X., & Wang, C. (2024). Downregulating DNA methyltransferase 3B by suppressing the PI3K/Akt signaling pathway enhances the chemosensitivity of glioblastoma to temozolomide. Molecular Neurobiology, 61(9), 7066-7074. https://doi.org/10.1007/s12035-024-04041-7

Vancouver

Kan W, Gao L, Chen J, Chen L, Zhang G, Hao B, et al. Downregulating DNA methyltransferase 3B by suppressing the PI3K/Akt signaling pathway enhances the chemosensitivity of glioblastoma to temozolomide. Molecular Neurobiology. 2024;61(9):7066-7074. doi:10.1007/s12035-024-04041-7

BibTeX
@article{Kan2024,
  author = {Kan, Wenwu and Gao, Linhui and Chen, Jingnan and Chen, Li and Zhang, Guojun and Hao, Bilie and He, Min and Chen, Xudong and Wang, Cheng},
  title = {Downregulating DNA methyltransferase 3B by suppressing the PI3K/Akt signaling pathway enhances the chemosensitivity of glioblastoma to temozolomide},
  journal = {Molecular Neurobiology},
  year = {2024},
  volume = {61},
  number = {9},
  pages = {7066--7074},
  doi = {10.1007/s12035-024-04041-7}
}
Kostenlos starten →